Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Johnson and Johnson
Harvard Business School
AstraZeneca
Moodys

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

B BRAUN Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for B BRAUN
International Patents:26
US Patents:2
Tradenames:225
Ingredients:62
NDAs:116

Drugs and US Patents for B BRAUN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun PHYSIOLYTE IN PLASTIC CONTAINER magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate SOLUTION;IRRIGATION 019024-001 Jun 8, 1984 RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
B Braun DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631-014 Feb 24, 1988 RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
B Braun ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate INJECTABLE;INJECTION 019873-001 Jun 10, 1993 RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
B Braun AMINO ACIDS amino acids INJECTABLE;INJECTION 091112-001 Apr 13, 2012 RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
B Braun HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER heparin sodium INJECTABLE;INJECTION 019952-004 Jul 20, 1992 AP RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
B Braun MANNITOL 10% IN PLASTIC CONTAINER mannitol INJECTABLE;INJECTION 020006-002 Jul 26, 1993 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
B Braun ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride INJECTABLE;INJECTION 018271-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for B BRAUN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
B Braun HEPATAMINE 8% amino acids INJECTABLE;INJECTION 018676-001 Aug 3, 1982 3,950,529 ⤷  Free Forever Trial
B Braun UCEPHAN sodium benzoate; sodium phenylacetate SOLUTION;ORAL 019530-001 Dec 23, 1987 4,284,647 ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for B BRAUN Drugs

Country Patent Number Estimated Expiration
Ukraine 115078 ⤷  Free Forever Trial
Cyprus 1114743 ⤷  Free Forever Trial
China 105283222 ⤷  Free Forever Trial
Spain 2441790 ⤷  Free Forever Trial
Russian Federation 2648823 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2007028788 ⤷  Free Forever Trial
South Korea 102162587 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for B BRAUN Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1912999 1490062-5 Sweden ⤷  Free Forever Trial PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
1666481 17C1031 France ⤷  Free Forever Trial PRODUCT NAME: TOFACITINIB,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,DONT LE CITRATE DE SODIUM; REGISTRATION NO/DATE: EU/1/17/1178 20170324
0812190 SPC/GB05/042 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: MESYLATE, ESYLATE OR SULFATE SALTS OF N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE); REGISTERED: UK EU/1/04/304/001 20050221; UK EU/1/04/304/002 20050221; UK EU/1/04/304/003 20050221; UK EU/1/04/304/004 20050221; UK EU/1/04/304/005 20050221; UK EU/1/04/304/006 20050221; UK EU/1/04/304/007 20050221
1392714 23/2017 Austria ⤷  Free Forever Trial PRODUCT NAME: OBETICHOLSAEURE, DESSEN PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE ODER AMINOSAEURE-KONJUGATE; REGISTRATION NO/DATE: EU/1/16/1139 20161212
2957286 2018C/047 Belgium ⤷  Free Forever Trial PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
1480644 2016C/069 Belgium ⤷  Free Forever Trial PRODUCT NAME: ZAVICEFTA (COMBINAISON DE CEFTAZIDIME ET AVIBACTAM); AUTHORISATION NUMBER AND DATE: EU/1/16/1109/001 20160628
0253310 SPC/GB95/010 United Kingdom ⤷  Free Forever Trial PRODUCT NAME: 2-N-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL) METHYL) -5-(HYDROXYMETHYL) IMIDAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT; REGISTERED: SE 12209 19940902; UK 0025/0324 19941215; UK 0025/0336 19941215
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Dow
AstraZeneca
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.